Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0345904 (
liver cancer
)
15,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Axl gene is known to encode for a receptor tyrosine kinase involved in the metastasis process of cancer. In this study, we investigated the underlying molecular mechanism of Axl alternative splicing.
Methods
: The expression levels of PTBP1 in hepatocellular carcinoma (HCC) tissues were obtained from TCGA samples and cell lines. The effect of
Axl-L
,
Axl-S
, and PTBP1 on cell growth, migration, invasion tumor formation, and metastasis of
liver cancer
cells were measured by cell proliferation, wound-healing, invasion, xenograft tumor formation, and metastasis. Interaction between PTBP1 and Axl was explored using cross-link immunoprecipitation, RNA pull-down assays and RNA immunoprecipitation assays.
Results
: Knockdown of the PTBP1 and exon 10 skipping isoform of Axl (Axl-S), led to impaired invasion and metastasis in hepatoma cells. Immunoprecipitation results indicated that
Axl-S
protein binds more robustly with Gas6 ligand than
Axl-L
(exon 10 including) and is more capable of promoting phosphorylation of ERK and AKT proteins. Furthermore, cross-link immunoprecipitation and RNA-pulldown assays revealed that PTBP1 binds to the polypyrimidine sequence
(TCCTCTCTGTCCTTTCTTC)
on
Axl
-Intron 9. MS2-GFP-IP experiments demonstrated that PTBP1 competes with
U2AF2
for binding to the aforementioned polypyrimidine sequence, thereby inhibiting alternative splicing and ultimately promoting
Axl-S
production.
Conclusion
: Our results highlight the biological significance of
Axl-S
and
PTBP1
in tumor metastasis, and show that PTBP1 affects the invasion and metastasis of hepatoma cells by modulating the alternative splicing of
Axl
exon 10.
...
PMID:Skipping of exon 10 in
Axl
pre-mRNA regulated by PTBP1 mediates invasion and metastasis process of liver cancer cells. 3248 14